首页/数据集/Medication/off-label indication dyads only found on QLD LAM and in the literature.

Medication/off-label indication dyads only found on QLD LAM and in the literature.

Figshare2021-12-03 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Medication_off-label_indication_dyads_only_found_on_QLD_LAM_and_in_the_literature_/17123436 数据链接链接失效反馈

官方服务：

资源简介：

Medication/off-label indication dyads only found on QLD LAM and in the literature.

应用场景：

创建时间：

2021-12-03

药物警戒

医疗器械不良反应

FDA不良事件报告系统公共仪表板是美国食品药品监督管理局(FDA)维护的数据库，用于收集和公开药品、生物制品和医疗器械的不良事件报告。该系统提供实时数据可视化，帮助医疗专业人员、研究人员和公众了解药物安全性和潜在风险。数据库包含来自医疗保健专业人员、消费者和制造商的自愿报告信息。

知名数据库190

Updated insights on levetiracetam-associated severe cutaneous adverse reactions: a real-world pharmacovigilance analysis

药物警戒

皮肤不良反应

Previous studies have explored the association between levetiracetam (LEV) and severe cutaneous adverse reactions (SCARs). However, most investigations have relied on clinical trial data or case repor

DataCite Commons2025-05-14 更新40

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine

药物警戒

药物不良反应监测

Gemcitabine is widely used in the treatment of various cancers. This study aims to evaluate gemcitabine-associated adverse events (AEs) using the Food and Drug Administration Adverse Event Reporting S

Taylor & Francis Group2025-03-13 更新40

BCG-associated death AE case reports from VAERS.

疫苗安全监测

药物警戒

BCG-associated death AE case reports from VAERS.

Figshare2016-10-18 更新60

Drug-induced skin ulcer: real-world pharmacovigilance analysis based on the FDA adverse event reporting system

药物不良反应监测

药物警戒

Skin ulcer (SU) may increase the risk of systemic infections and have evolved into an important public health problem. However, there is a lack of research specifically on drug-induced SU. We extracte

Taylor & Francis Group2025-05-14 更新40

Medication/off-label indication dyads only found on QLD LAM and in the literature.

资源简介：

相关数据集